
Bio-Rad Laboratories BIO
€ 230.66
-1.15%
Quartalsbericht 2025-Q2
hinzugefügt 31.07.2025
Bio-Rad Laboratories Langfristige Verbindlichkeiten 2011-2026 | BIO
Langfristige Verbindlichkeiten Jährlich Bio-Rad Laboratories
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 1.35 B | 1.14 B | 840 M | 792 M | 780 M | 709 M | 715 M | 956 M | 893 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.35 B | 709 M | 908 M |
Langfristige Verbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Langfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Aethlon Medical
AEMD
|
42.5 K | $ 2.22 | - | $ 3.47 M | ||
|
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | ||
|
AdaptHealth Corp.
AHCO
|
424 M | $ 10.36 | -0.86 % | $ 1.4 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | ||
|
Alphatec Holdings
ATEC
|
89.9 M | $ 12.95 | -0.77 % | $ 1.94 B | ||
|
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | ||
|
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | ||
|
Cognyte Software Ltd.
CGNT
|
1.33 M | $ 8.36 | - | $ 600 M | ||
|
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | ||
|
ClearPoint Neuro
CLPT
|
23.9 M | $ 10.09 | -9.59 % | $ 286 M | ||
|
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | ||
|
Boston Scientific Corporation
BSX
|
11.8 B | $ 70.55 | -0.98 % | $ 104 B | ||
|
Cytosorbents Corporation
CTSO
|
14 M | $ 0.68 | 0.71 % | $ 37 M | ||
|
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | ||
|
EDAP TMS S.A.
EDAP
|
7.44 M | $ 4.0 | -1.23 % | $ 149 M | ||
|
CONMED Corporation
CNMD
|
877 M | $ 36.89 | -0.78 % | $ 1.14 B | ||
|
InMode Ltd.
INMD
|
12.5 M | $ 13.65 | - | $ 882 M | ||
|
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | ||
|
Establishment Labs Holdings
ESTA
|
53.7 M | $ 64.4 | -0.95 % | $ 1.91 B | ||
|
Cutera
CUTR
|
430 M | - | -10.19 % | $ 1.99 M | ||
|
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | ||
|
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | ||
|
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M | ||
|
FONAR Corporation
FONR
|
36.4 M | $ 18.43 | -0.11 % | $ 121 M | ||
|
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | ||
|
Abbott Laboratories
ABT
|
25.7 B | $ 109.42 | -1.2 % | $ 191 B | ||
|
Delcath Systems
DCTH
|
2.52 M | $ 9.58 | -1.64 % | $ 343 M | ||
|
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.33 | - | $ 21.5 M | ||
|
OrthoPediatrics Corp.
KIDS
|
116 M | $ 17.02 | -1.07 % | $ 399 M | ||
|
Helius Medical Technologies
HSDT
|
252 K | $ 2.11 | -2.88 % | $ 1.28 M | ||
|
AxoGen
AXGN
|
1.61 M | $ 32.52 | -0.7 % | $ 1.5 B | ||
|
Align Technology
ALGN
|
184 M | $ 174.5 | -0.92 % | $ 13.1 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
1.56 B | $ 8.95 | -1.65 % | $ 689 M | ||
|
Bruker Corporation
BRKR
|
1.28 B | $ 33.37 | -1.1 % | $ 4.97 K | ||
|
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | ||
|
Apyx Medical Corporation
APYX
|
1.1 M | $ 3.8 | 1.6 % | $ 156 M | ||
|
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | ||
|
Accuray Incorporated
ARAY
|
196 M | $ 0.38 | -1.84 % | $ 39.1 M | ||
|
IRadimed Corporation
IRMD
|
4.76 M | $ 102.06 | -0.72 % | $ 1.3 B |